Incorporated in 1988, Wanbury Ltd is in the business of pharmaceutical and related activities, including research
Financial Results:
Wanbury Ltd reported Revenues for Q4FY24 of ₹139.41 Crores up from ₹132.98 Crore year on year, a rise of 4.84%.
Total Expenses for Q4FY24 of ₹131.98 Crores up from ₹129.41 Crores year on year, a rise of 1.99%.
Consolidated Net Profit of ₹33.63 Crores up 3197.06% from ₹1.02 Crores in the same quarter of the previous year.
The Earnings per Share is ₹10.27, up 3,212.90% from ₹0.31 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.